The latest development of Wuxi PharmaTech New Drug Development Co., Ltd.

WuXi PharmaTech put into use the world's largest 2000-liter disposable bioreactor, creating a precedent for culturing NS0 cells in disposable bioreactor.

WuXi PharmaTech Genomics Clinical Laboratory has obtained CLIA certification in the United States.

Yaomingkang announced an authorization agreement with Mayo Clinic.

Wuxi pharmatech and American OMT company expand human antibody research and development and business opportunities to serve Asian and global pharmaceutical companies.

WuXi PharmaTech and PRA set up a joint venture company to provide clinical research services for China market.

AstraZeneca MedImmune and Wuxi PharmaTech announced the establishment of a joint venture to jointly develop and produce innovative biopharmaceuticals for the China market.

Optics Valley Pharmaceutical has become the largest outsourcer in the central and western regions.

2065438+0310/0/8, the reporter learned from the Ministry of Commerce that in the latest ranking of offshore service outsourcing enterprises, Wuxi PharmaTech Wuhan Company became the largest offshore service outsourcing enterprise in Hubei and the largest pharmaceutical R&D outsourcing enterprise in the central and western regions.